1. Clinical and laboratory parameters predicting a requirement for the reevaluation of growth hormone status during growth hormone treatment: Retesting early in the course of GH treatment. (June 2017) Authors: Vuralli, Dogus; Gonc, E. Nazli; Ozon, Z. Alev; Alikasifoglu, Ayfer; Kandemir, Nurgun Journal: Growth hormone & IGF research Issue: Volume 34(2017) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Approach to Hypocalcemia in Newborn Period and Infancy: Who Should Be Treated?. (19th June 2019) Authors: Vuralli, Dogus Other Names: Kaskel F. J. Academic Editor. Journal: International journal of pediatrics Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. HDAC4 mutations cause diabetes and induce β‐cell FoxO1 nuclear exclusion. Issue 5 (9th April 2019) Authors: Gong, Maolian; Yu, Yong; Liang, Lei; Vuralli, Dogus; Froehler, Sebastian; Kuehnen, Peter; Du Bois, Philipp; Zhang, Jingjing; Cao, Aidi; Liu, Yuantao; Hussain, Khalid; Fielitz, Jens; Jia, Shiqi; Chen, Wei; Raile, Klemens Journal: Molecular genetics & genomic medicine Issue: Volume 7:Issue 5(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Which parameters predict the beneficial effect of GnRHa treatment on height in girls with central precocious puberty?. (7th February 2021) Authors: Vuralli, Dogus; Gonc, Nazli E.; Ozon, Zeynep Alev; Kandemir, Nurgun; Alikasifoglu, Ayfer Journal: Clinical endocrinology Issue: Volume 94:Number 5(2021) Page Start: 804 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗